HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Choroid Neoplasms D002830 2 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Mercury Poisoning, Nervous System D020262 2 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Echinococcosis D004443 2 associated lipids
Tularemia D014406 3 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Carcinoma, Mucoepidermoid D018277 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Aoki M et al. Expression of BMP-7 in human gastric cancer and its clinical significance. 2011 Br. J. Cancer pmid:21224856
Maeda S et al. Clinical significance of midkine expression in pancreatic head carcinoma. 2007 Br. J. Cancer pmid:17622248
Kawaguchi Y et al. Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma. 2007 Br. J. Cancer pmid:17622245
Liu WM et al. Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). 2009 Br. J. Cancer pmid:19638977
Konishi N et al. Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas. 2003 Br. J. Cancer pmid:12698188
Takizawa S et al. Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer. 2003 Br. J. Cancer pmid:12698186
Eichenmüller M et al. Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma. 2010 Br. J. Cancer pmid:20517313
Nakagawa S et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. 2004 Br. J. Cancer pmid:14710229
Brownhill SC et al. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. 2007 Br. J. Cancer pmid:17533400
Lorch G et al. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. 2007 Br. J. Cancer pmid:17533397
Abd El-Rehim DM et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. 2004 Br. J. Cancer pmid:15480434
Bjørge T et al. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. 2004 Br. J. Cancer pmid:15477862
Hussain SA et al. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:12592374
Spizzo G et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. 2003 Br. J. Cancer pmid:12592372
Pelosi G et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. 2003 Br. J. Cancer pmid:12592367
Unoki M et al. UHRF1 is a novel diagnostic marker of lung cancer. 2010 Br. J. Cancer pmid:20517312
Millar EK et al. BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. 2009 Br. J. Cancer pmid:19066611
Li Q et al. Expression of interferon-gamma in human adrenal gland and kidney tumours. 2007 Br. J. Cancer pmid:17622250
Nishikawa M et al. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. 2005 Br. J. Cancer pmid:15956973
Clark SE et al. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. 2011 Br. J. Cancer pmid:21139586
Onda M et al. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. 2005 Br. J. Cancer pmid:15956966
Ni X et al. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. 2004 Br. J. Cancer pmid:15305183
Takano T et al. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. 2007 Br. J. Cancer pmid:17453004
Koukourakis MI et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. 2003 Br. J. Cancer pmid:12942121
Grunewald TG et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. 2007 Br. J. Cancer pmid:17211471
Fareed KR et al. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. 2010 Br. J. Cancer pmid:20461087
Frietsch JJ et al. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. 2010 Br. J. Cancer pmid:20461080
Bibi R et al. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. 2006 Br. J. Cancer pmid:17031402
Bruland O et al. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. 2008 Br. J. Cancer pmid:18349847
Yoshioka T et al. Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18349839
Maeda S et al. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. 2008 Br. J. Cancer pmid:18349830
Schmitz M et al. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. 2007 Br. J. Cancer pmid:17375044
Comstock CE et al. Impact of differential cyclin D1 expression and localisation in prostate cancer. 2007 Br. J. Cancer pmid:17375037
Ogawa E et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. 2004 Br. J. Cancer pmid:15226767
Shehata M et al. Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy. 2009 Br. J. Cancer pmid:19755991
Lugli A et al. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. 2009 Br. J. Cancer pmid:19755986
Angst E et al. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. 2006 Br. J. Cancer pmid:16832411
Chen YL et al. Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. 2002 Br. J. Cancer pmid:12177809
Baeten CI et al. Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. 2002 Br. J. Cancer pmid:12177806
Somlo G et al. Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. 2002 Br. J. Cancer pmid:12177795
Volm M et al. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. 2002 Br. J. Cancer pmid:12177790
Sheridan J et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. 2009 Br. J. Cancer pmid:19066606
Ameri K et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. 2010 Br. J. Cancer pmid:20051957
van Beers EH et al. A multiplex PCR predictor for aCGH success of FFPE samples. 2006 Br. J. Cancer pmid:16333309
Batistatou A et al. Involvement of dysadherin and E-cadherin in the development of testicular tumours. 2005 Br. J. Cancer pmid:16333245
McCallum M et al. A prognostic index for operable, node-negative breast cancer. 2004 Br. J. Cancer pmid:15138474
Chakraborty S et al. Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. 2011 Br. J. Cancer pmid:21224854
Matsuyoshi S et al. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. 2006 Br. J. Cancer pmid:16450001
Hildenbrand R and Arens N Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue. 2004 Br. J. Cancer pmid:15226768
Hart CA et al. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. 2002 Br. J. Cancer pmid:11953862
Shinto O et al. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. 2010 Br. J. Cancer pmid:20145621
Ueno Y et al. Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. 2005 Br. J. Cancer pmid:15841081
Kato T et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. 2005 Br. J. Cancer pmid:16251871
Kölby L et al. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. 2005 Br. J. Cancer pmid:16251870
Dai DL et al. Reduced Apaf-1 expression in human cutaneous melanomas. 2004 Br. J. Cancer pmid:15305193
Hosono S et al. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. 2007 Br. J. Cancer pmid:17211477
Kamoshida S et al. Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. 2007 Br. J. Cancer pmid:17211470
Grützmann R et al. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. 2004 Br. J. Cancer pmid:14997207
Vicent S et al. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. 2004 Br. J. Cancer pmid:14997206
Savinainen KJ et al. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. 2004 Br. J. Cancer pmid:14997205
Takemoto S et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. 2009 Br. J. Cancer pmid:19638983
Rofstad EK and Halsør EF Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. 2002 Br. J. Cancer pmid:11870523
Cheng Q et al. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 2002 Br. J. Cancer pmid:11870519
Brooks LA et al. E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. 2002 Br. J. Cancer pmid:11870517
Horiguchi J et al. Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer. 2002 Br. J. Cancer pmid:11870510
Almstrup K et al. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. 2010 Br. J. Cancer pmid:20823885
Ivarsson K et al. Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. 2005 Br. J. Cancer pmid:16091763
Theodore Ch et al. Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. 2004 Br. J. Cancer pmid:14710206
Myers E et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. 2004 Br. J. Cancer pmid:15477868
Kostourou V et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. 2011 Br. J. Cancer pmid:21139581
Cui T et al. DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. 2011 Br. J. Cancer pmid:21364582
Verschoyle RD et al. Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. 2007 Br. J. Cancer pmid:17211473
Knijn N et al. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. 2011 Br. J. Cancer pmid:21364579
Lopez-Crapez E et al. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. 2005 Br. J. Cancer pmid:15956964
Dangles V et al. Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. 2002 Br. J. Cancer pmid:11953886
Farooqui M et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. 2007 Br. J. Cancer pmid:17971769
Mellor P et al. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. 2007 Br. J. Cancer pmid:17726466
Yamamoto E et al. Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. 2007 Br. J. Cancer pmid:17971775
Hagiwara S et al. Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. 2007 Br. J. Cancer pmid:17971768
Al-Attar A et al. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. 2010 Br. J. Cancer pmid:20087352
Jeon TY et al. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. 2010 Br. J. Cancer pmid:20087351
Brown NS et al. Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. 2005 Br. J. Cancer pmid:15841086
Langbein S et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 2006 Br. J. Cancer pmid:16465194
Wülfing P et al. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. 2005 Br. J. Cancer pmid:15841074
Hudelist G et al. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. 2003 Br. J. Cancer pmid:12966413
Vernimmen D et al. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. 2003 Br. J. Cancer pmid:12942124
Seynhaeve AL et al. Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. 2002 Br. J. Cancer pmid:11953868
Dive C et al. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. 2010 Br. J. Cancer pmid:20051949
Lawrie LC et al. Liver fatty acid binding protein expression in colorectal neoplasia. 2004 Br. J. Cancer pmid:15138477
Radke I et al. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. 2006 Br. J. Cancer pmid:16832410
Fondevila C et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. 2004 Br. J. Cancer pmid:14710231
Nomura H et al. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. 2007 Br. J. Cancer pmid:17726464
Yamamoto T et al. No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. 2003 Br. J. Cancer pmid:12838317
Horii R et al. Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer. 2007 Br. J. Cancer pmid:17726451
Shyu RY et al. RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma. 2003 Br. J. Cancer pmid:12838316
Xue SA et al. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? 2003 Br. J. Cancer pmid:12838311
Southern SA et al. Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. 2004 Br. J. Cancer pmid:15138476
Lawrence CM et al. Prospective study of formalin-fixed Mohs surgery and haematoxylin and eosin stains with control contralateral biopsies for lentigo maligna: 5-year follow-up results. 2014 Br. J. Dermatol. pmid:24446749
Chen CS et al. Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. 2005 Br. J. Dermatol. pmid:16225620
Vila AT et al. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients. 2005 Br. J. Dermatol. pmid:16086759